BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 19801490)

  • 1. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
    Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K/Akt/mTOR signaling pathway.
    Wu Y; Wang J; Yu X; Li D; Han X; Fan L
    Cardiol J; 2017; 24(4):409-418. PubMed ID: 28198521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of Neuregulin-1/ErbB signaling in the hippocampus of rats after administration of doxorubicin.
    Liao D; Guo Y; Xiang D; Dang R; Xu P; Cai H; Cao L; Jiang P
    Drug Des Devel Ther; 2018; 12():231-239. PubMed ID: 29430172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micheliolide Protects Against Doxorubicin-Induced Cardiotoxicity in Mice by Regulating PI3K/Akt/NF-kB Signaling Pathway.
    Kalantary-Charvadeh A; Sanajou D; Hemmati-Dinarvand M; Marandi Y; Khojastehfard M; Hajipour H; Mesgari-Abbasi M; Roshangar L; Nazari Soltan Ahmad S
    Cardiovasc Toxicol; 2019 Aug; 19(4):297-305. PubMed ID: 30835049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
    Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
    Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
    Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
    J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuregulin-1β promotes glucose uptake via PI3K/Akt in neonatal rat cardiomyocytes.
    Pentassuglia L; Heim P; Lebboukh S; Morandi C; Xu L; Brink M
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E782-94. PubMed ID: 26979522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
    Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
    J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal di-(2-ethylhexyl) phthalate exposure induced myocardial cytotoxicity via the regulation of the NRG1-dependent ErbB2/ErbB4-PI3K/AKT signaling pathway in fetal mice.
    Yu D; Zhu D; Wang X; Li B; Li J; Lu P; Ji Y; Wang X
    Ecotoxicol Environ Saf; 2022 Aug; 241():113771. PubMed ID: 35716406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.
    Adamcová M; Šimůnek T; Kaiserová H; Popelová O; Štěrba M; Potáčová A; Vávrová J; Maláková J; Geršl V
    Toxicology; 2007 Jul; 237(1-3):218-228. PubMed ID: 17587482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acylated Ghrelin Protects the Hearts of Rats from Doxorubicin-Induced Fas/FasL Apoptosis by Stimulating SERCA2a Mediated by Activation of PKA and Akt.
    Shati AA; Dallak M
    Cardiovasc Toxicol; 2019 Dec; 19(6):529-547. PubMed ID: 31093930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin-1 protects against doxorubicin-induced apoptosis in cardiomyocytes through an Akt-dependent pathway.
    An T; Zhang Y; Huang Y; Zhang R; Yin S; Guo X; Wang Y; Zou C; Wei B; Lv R; Zhou Q; Zhang J
    Physiol Res; 2013; 62(4):379-85. PubMed ID: 23590603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction.
    Negoro S; Oh H; Tone E; Kunisada K; Fujio Y; Walsh K; Kishimoto T; Yamauchi-Takihara K
    Circulation; 2001 Jan; 103(4):555-61. PubMed ID: 11157722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant low-dose doxorubicin treatment and exercise.
    Sturgeon K; Schadler K; Muthukumaran G; Ding D; Bajulaiye A; Thomas NJ; Ferrari V; Ryeom S; Libonati JR
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R685-92. PubMed ID: 25009215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1beta and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity.
    Sawyer DB; Zuppinger C; Miller TA; Eppenberger HM; Suter TM
    Circulation; 2002 Apr; 105(13):1551-4. PubMed ID: 11927521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
    Abbas NAT; Kabil SL
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes.
    Yamamoto Y; Hoshino Y; Ito T; Nariai T; Mohri T; Obana M; Hayata N; Uozumi Y; Maeda M; Fujio Y; Azuma J
    Cardiovasc Res; 2008 Jul; 79(1):89-96. PubMed ID: 18346979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity.
    George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverging effects of enalapril or eplerenone in primary prevention against doxorubicin-induced cardiotoxicity.
    Hullin R; Métrich M; Sarre A; Basquin D; Maillard M; Regamey J; Martin D
    Cardiovasc Res; 2018 Feb; 114(2):272-281. PubMed ID: 29016737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.